Clinical trial NCT02129634 - References

Peripheral Arterial Disease — Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) Trial

Citation(s)

•   Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H; BASIL trial participants
  Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005 Dec 3;366(9501):1925-34.
•   Aoki J, Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka K, Schiele F, Russell ME, Koglin J, Serruys PW; TAXUS II Study Group
  Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study. Circulation. 2005 Dec 20;112(25):3876-83. Epub 2005 Dec 12.
•   Beard JD
  Should we save critically ischaemic legs at any cost? Acta Chir Belg. 2008 Nov-Dec;108(6):651-5.
•   Colombo A, Cosgrave J
  Paclitaxel-eluting stents in complex lesions. JAMA. 2005 Sep 14;294(10):1268-70.
•   Dawkins KD, Grube E, Guagliumi G, Banning AP, Zmudka K, Colombo A, Thuesen L, Hauptman K, Marco J, Wijns W, Popma JJ, Koglin J, Russell ME; TAXUS VI Investigators
  Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation. 2005 Nov 22;112(21):3306-13. Epub 2005 Nov 14.
•   Fanelli F, Cannavale A, Boatta E, Corona M, Lucatelli P, Wlderk A, Cirelli C, Salvatori FM
  Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther. 2012 Oct;19(5):571-80. doi: 10.1583/JEVT-12-3926MR.1.
•   Klevsgård R, Hallberg IR, Risberg B, Thomsen MB
  The effects of successful intervention on quality of life in patients with varying degrees of lower-limb ischaemia. Eur J Vasc Endovasc Surg. 2000 Mar;19(3):238-45.
•   Meltzer MI
  Introduction to health economics for physicians. Lancet. 2001 Sep 22;358(9286):993-8.
•   Met R, Koelemay MJ, Bipat S, Legemate DA, van Lienden KP, Reekers JA
  Always contact a vascular interventional specialist before amputating a patient with critical limb ischemia. Cardiovasc Intervent Radiol. 2010 Jun;33(3):469-74. doi: 10.1007/s00270-009-9687-3. Epub 2009 Aug 18.
•   Moriarty JP, Murad MH, Shah ND, Prasad C, Montori VM, Erwin PJ, Forbes TL, Meissner MH, Stoner MC; Society for Vascular Surgery Committee on Comparative Effectiveness
  A systematic review of lower extremity arterial revascularization economic analyses. J Vasc Surg. 2011 Oct;54(4):1131-1144.e1. doi: 10.1016/j.jvs.2011.04.058. Review.
•   Pell JP, Donnan PT, Fowkes FG, Ruckley CV
  Quality of life following lower limb amputation for peripheral arterial disease. Eur J Vasc Surg. 1993 Jul;7(4):448-51.
•   Peregrin JH, Koznar B, Kovác J, Lastovicková J, Novotný J, Vedlich D, Skibová J
  PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol. 2010 Aug;33(4):720-5. doi: 10.1007/s00270-010-9881-3. Epub 2010 May 11.
•   Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G
  Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004 Aug 17;110(7):810-4. Epub 2004 Aug 9.
•   Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Bräunlich S, Ick H, Schuster J, Botsios S, Kruse HJ, Varcoe RL, Scheinert D
  First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol. 2011 Sep 6;58(11):1105-9. doi: 10.1016/j.jacc.2011.05.034.
•   Serruys PW, Kutryk MJ, Ong AT
  Coronary-artery stents. N Engl J Med. 2006 Feb 2;354(5):483-95. Review.
•   Shiroiwa T, Sung YK, Fukuda T, Lang HC, Bae SC, Tsutani K
  International survey on willingness-to-pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? Health Econ. 2010 Apr;19(4):422-37. doi: 10.1002/hec.1481.
•   Siablis D, Kraniotis P, Karnabatidis D, Kagadis GC, Katsanos K, Tsolakis J
  Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther. 2005 Dec;12(6):685-95.
•   Singh S, Evans L, Datta D, Gaines P, Beard JD
  The costs of managing lower limb-threatening ischaemia. Eur J Vasc Endovasc Surg. 1996 Oct;12(3):359-62.
•   Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME; TAXUS V Investigators
  Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005 Sep 14;294(10):1215-23.
•   Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME; TAXUS-IV Investigators
  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004 Jan 15;350(3):221-31.
•   Sum CF, Lim SC, Tavintharan S
  Peripheral arterial disease and diabetes foot care. Singapore Med J. 2008 Feb;49(2):93-4.
•   Taneja M, Tay KH, Sebastian M, Pasupathy S, Lin SE, Teo T, Low R, Irani FG, Chng SP, Dewan A, Tan BS
  Self-expanding nitinol stents in recanalisation of long-length superficial femoral artery occlusions in patients with critical limb ischaemia. Singapore Med J. 2009 Dec;50(12):1184-8.
•   Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U
  Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008 Feb 14;358(7):689-99. doi: 10.1056/NEJMoa0706356.
•   Tsetis D, Belli AM
  The role of infrapopliteal angioplasty. Br J Radiol. 2004 Dec;77(924):1007-15. Review.
•   Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U, Ricke J
  Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008 Sep 23;118(13):1358-65. doi: 10.1161/CIRCULATIONAHA.107.735985. Epub 2008 Sep 8. Erratum in: Circulation. 2008 Oct 14;118(16):e670.
•   Wiskirchen J, Schöber W, Schart N, Kehlbach R, Wersebe A, Tepe G, Claussen CD, Duda SH
  The effects of paclitaxel on the three phases of restenosis: smooth muscle cell proliferation, migration, and matrix formation: an in vitro study. Invest Radiol. 2004 Sep;39(9):565-71.

Singapore INfra-Genicular Angioplasty With PAclitaxel-eluting Balloon for Critical Limb Ischaemia (SINGA-PACLI) Trial

Details for clinical trial NCT02129634